| 2016-10-19 07:03:33|
MRUS 07:03 10/19 10/19/16
Merus receives undisclosed milestone payment from Ono Pharmaceutical
Merus announced that the company received an undisclosed milestone payment from Ono Pharmaceutical, under the ongoing collaboration between the two companies. The milestone was triggered as a result of pre-clinical confirmatory studies using the selected lead bispecific antibody candidate that Ono intends to advance into clinical testing. Ono and Merus have also extended their collaboration by signing an additional agreement for CMC activities to be carried out by Merus.